Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing...
-
Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma1 Milestone is a testament to ten years of daratumumab experience and...
-
25 March 2026 Announcement no. 3 Pharma Equity Group A/S - Annual Report 2025 Pharma Equity Group A/S - Annual Report 2025 – Highlights of the year Today, the Board of Directors of Pharma Equity...
-
Kenmare Resources plc (“Kenmare” or the “Company” or the “Group”) 25 March 2026 2025 PRELIMINARY RESULTS Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium...
-
The Supervisory Board of TextMagic AS has approved the company’s consolidated audited annual report for the financial year 2025. There are no material differences in the financial results of the...
-
2025 full year results EBITDA and capacity targets achieved With SPRING: activities refocused, leaner organization and reduction in the number of countries 2025 full year results Turnover: +16% at...
-
Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 Teclistamab monotherapy delivered superior progression-free...
-
Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall...
-
Atos Group Full Year 2025 Results
-
Edinburgh, UK, March 05, 2026 (GLOBE NEWSWIRE) -- PartnerBridge, the partner discovery and activation platform, today announced a string of milestones demonstrating its growing traction and market...